Stock Earnings

Question 1

What are Cardiff Oncology Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Cardiff Oncology Inc has a total asset of $97, Net loss of $-45

Question 2

What are the key financial ratios for CRDF?

Accepted Answer

Cardiff Oncology Inc's Current ratio is 6.92, has a Net margin is 0, sales per share of $0.

Question 3

How is Cardiff Oncology Inc's revenue broken down by segment or geography?

Accepted Answer

Cardiff Oncology Inc largest revenue segment is Novel Therapies for Cancers, at a revenue of 683,000 in the most earnings release.For geography, United States is the primary market for Cardiff Oncology Inc, at a revenue of 683,000.

Question 4

Is Cardiff Oncology Inc profitable?

Accepted Answer

no, according to the latest financial statements, Cardiff Oncology Inc has a net loss of $-45

Question 5

Does Cardiff Oncology Inc have any liabilities?

Accepted Answer

yes, Cardiff Oncology Inc has liability of 14

Question 6

How many outstanding shares for Cardiff Oncology Inc?

Accepted Answer

Cardiff Oncology Inc has a total outstanding shares of 66.52

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	14	12	13	13	11	8
Research & Development	39	36	32	27	17	11
Operating Expenses	54	49	45	40	29	19
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-50	-45	-41	-38	-28	-19
Income Tax Expense	--	0	0	0	0	0
Net Income	-50	-45	-41	-38	-28	-22
Net Income Growth	16%	10%	8%	36%	27%	38%
Shares Outstanding (Diluted)	67	47.65	44.67	43.6	39.03	20.87
Shares Change (YoY)	43%	7%	2%	12%	87%	250%
EPS (Diluted)	-0.74	-0.95	-0.92	-0.89	-0.73	-1.08
EPS Growth	-19%	3%	4%	22%	-32%	-61%
Free Cash Flow	-43	-37	-31	-34	-23	-16
Free Cash Flow Per Share	-0.64	-0.77	-0.69	-0.77	-0.58	-0.76
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-54	-48	-45	-39	-28	-19
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-54	-48	-45	-39	-28	-19
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Cardiff Oncology Inc (CRDF) Price

CRDF Stock Price Chart

CRDF Income

Follow-Up Questions